Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6ES1

Crystal structure of the binding domain from botulinum neurotoxin A2 bound to extracellular domain of human receptor SV2C

6ES1 の概要
エントリーDOI10.2210/pdb6es1/pdb
分子名称Botulinum neurotoxin type A, Synaptic vesicle glycoprotein 2C, ACETATE ION, ... (4 entities in total)
機能のキーワードreceptor, human, clostridium botulinum, binding domain, sv2c, protein binding
由来する生物種Clostridium botulinum
詳細
細胞内の位置Botulinum neurotoxin A light chain: Secreted. Botulinum neurotoxin A heavy chain: Secreted: Q45894
Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane ; Multi- pass membrane protein : Q496J9
タンパク質・核酸の鎖数2
化学式量合計65580.88
構造登録者
Gustafsson, R.,Masuyer, G.,Stenmark, P. (登録日: 2017-10-19, 公開日: 2018-04-25, 最終更新日: 2024-01-17)
主引用文献Gustafsson, R.,Zhang, S.,Masuyer, G.,Dong, M.,Stenmark, P.
Crystal Structure of Botulinum Neurotoxin A2 in Complex with the Human Protein Receptor SV2C Reveals Plasticity in Receptor Binding.
Toxins (Basel), 10:-, 2018
Cited by
PubMed Abstract: Botulinum neurotoxins (BoNTs) are a family of highly dangerous bacterial toxins, with seven major serotypes (BoNT/A-G). Members of BoNTs, BoNT/A1 and BoNT/B1, have been utilized to treat an increasing number of medical conditions. The clinical trials are ongoing for BoNT/A2, another subtype of BoNT/A, which showed promising therapeutic properties. Both BoNT/A1 and BoNT/A2 utilize three isoforms of synaptic vesicle protein SV2 (SV2A, B, and C) as their protein receptors. We here present a high resolution (2.0 Å) co-crystal structure of the BoNT/A2 receptor-binding domain in complex with the human SV2C luminal domain. The structure is similar to previously reported BoNT/A-SV2C complexes, but a shift of the receptor-binding segment in BoNT/A2 rotates SV2C in two dimensions giving insight into the dynamic behavior of the interaction. Small differences in key residues at the binding interface may influence the binding to different SV2 isoforms, which may contribute to the differences between BoNT/A1 and BoNT/A2 observed in the clinic.
PubMed: 29649119
DOI: 10.3390/toxins10040153
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2 Å)
構造検証レポート
Validation report summary of 6es1
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon